Roivant Sciences (ROIV) PT Lowered to $13 at Truist Securities on ARU-1801 Discontinuation, Buy Reiterated
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas lowered the price target on Roivant Sciences (NASDAQ: ROIV) to $13.00 (from $15.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
